{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["apple-derived pectin", "gut barrier function", "gut microbiota", "metabolic endotoxemia", "obesity"]], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "26938554", "DateCompleted": {"Year": "2016", "Month": "12", "Day": "13"}, "DateRevised": {"Year": "2022", "Month": "04", "Day": "09"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "02", "Day": "29"}], "ELocationID": ["126", "10.3390/nu8030126"], "Language": ["eng"], "Journal": {"ISSN": "2072-6643", "JournalIssue": {"Volume": "8", "Issue": "3", "PubDate": {"Year": "2016", "Month": "Feb", "Day": "29"}}, "Title": "Nutrients", "ISOAbbreviation": "Nutrients"}, "ArticleTitle": "Apple-Derived Pectin Modulates Gut Microbiota, Improves Gut Barrier Function, and Attenuates Metabolic Endotoxemia in Rats with Diet-Induced Obesity.", "Pagination": {"StartPage": "126", "MedlinePgn": "126"}, "Abstract": {"AbstractText": ["This study was aimed at determining potential effects of apple-derived pectin on weight gain, gut microbiota, gut barrier and metabolic endotoxemia in rat models of diet-induced obesity. The rats received a standard diet (control; Chow group; n = 8) or a high-fat diet (HFD; n = 32) for eight weeks to induce obesity. The top 50th percentile of weight-gainers were selected as diet induced obese rats. Thereafter, the Chow group continued on chow, and the diet induced obese rats were randomly divided into two groups and received HFD (HF group; n = 8) or pectin-supplemented HFD (HF-P group; n = 8) for six weeks. Compared to the HF group, the HF-P group showed attenuated weight gain (207.38 \u00b1 7.96 g vs. 283.63 \u00b1 10.17 g, p < 0.01) and serum total cholesterol level (1.46 \u00b1 0.13 mmol/L vs. 2.06 \u00b1 0.26 mmol/L, p < 0.01). Compared to the Chow group, the HF group showed a decrease in Bacteroidetes phylum and an increase in Firmicutes phylum, as well as subordinate categories (p < 0.01). These changes were restored to the normal levels in the HF-P group. Furthermore, compared to the HF group, the HF-P group displayed improved intestinal alkaline phosphatase (0.57 \u00b1 0.20 vs. 0.30 \u00b1 0.19, p < 0.05) and claudin 1 (0.76 \u00b1 0.14 vs. 0.55 \u00b1 0.18, p < 0.05) expression, and decreased Toll-like receptor 4 expression in ileal tissue (0.76 \u00b1 0.58 vs. 2.04 \u00b1 0.89, p < 0.01). The HF-P group also showed decreased inflammation (TNF\u03b1: 316.13 \u00b1 7.62 EU/mL vs. 355.59 \u00b1 8.10 EU/mL, p < 0.01; IL-6: 51.78 \u00b1 2.35 EU/mL vs. 58.98 \u00b1 2.59 EU/mL, p < 0.01) and metabolic endotoxemia (2.83 \u00b1 0.42 EU/mL vs. 0.68 \u00b1 0.14 EU/mL, p < 0.01). These results suggest that apple-derived pectin could modulate gut microbiota, attenuate metabolic endotoxemia and inflammation, and consequently suppress weight gain and fat accumulation in diet induced obese rats."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China. jiangtingting08med@163.com."}], "LastName": "Jiang", "ForeName": "Tingting", "Initials": "T"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China. xuejingao870214@163.com."}], "LastName": "Gao", "ForeName": "Xuejin", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China. wuchao0008@163.com."}], "LastName": "Wu", "ForeName": "Chao", "Initials": "C"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China. tianfeng_nju@163.com."}], "LastName": "Tian", "ForeName": "Feng", "Initials": "F"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China. lqiuchenggd@163.com."}, {"Identifier": [], "Affiliation": "Department of General Surgery, South Medical University, Guangzhou 510515, China. lqiuchenggd@163.com."}], "LastName": "Lei", "ForeName": "Qiucheng", "Initials": "Q"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China. ahbijingcheng@163.com."}], "LastName": "Bi", "ForeName": "Jingcheng", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University, Pukou District, Nanjing 210061, China. xiebx@nicemice.cn."}], "LastName": "Xie", "ForeName": "Bingxian", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University, Pukou District, Nanjing 210061, China. wanghy@nicemice.cn."}], "LastName": "Wang", "ForeName": "Hong Yu", "Initials": "HY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Pharmaceutical Biotechnology and MOE Key Laboratory of Model Animal for Disease Study, Model Animal Research Center, Nanjing University, Pukou District, Nanjing 210061, China. schen6@163.com."}], "LastName": "Chen", "ForeName": "Shuai", "Initials": "S"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of General Surgery, Jinling Hospital, Medical School of Nanjing University, Nanjing 210002, China. wxinying@263.net."}], "LastName": "Wang", "ForeName": "Xinying", "Initials": "X"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Nutrients", "NlmUniqueID": "101521595", "ISSNLinking": "2072-6643"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Obesity Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biomarkers"}, {"RegistryNumber": "0", "NameOfSubstance": "Inflammation Mediators"}, {"RegistryNumber": "0", "NameOfSubstance": "Lipopolysaccharides"}, {"RegistryNumber": "89NA02M4RX", "NameOfSubstance": "Pectins"}, {"RegistryNumber": "97C5T2UQ7J", "NameOfSubstance": "Cholesterol"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Anti-Obesity Agents"}, {"QualifierName": ["classification", "drug effects", "metabolism"], "DescriptorName": "Bacteria"}, {"QualifierName": ["blood"], "DescriptorName": "Biomarkers"}, {"QualifierName": ["blood"], "DescriptorName": "Cholesterol"}, {"QualifierName": [], "DescriptorName": "Diet, High-Fat"}, {"QualifierName": [], "DescriptorName": "Disease Models, Animal"}, {"QualifierName": ["blood", "etiology", "microbiology", "prevention & control"], "DescriptorName": "Endotoxemia"}, {"QualifierName": [], "DescriptorName": "Fruit"}, {"QualifierName": ["drug effects"], "DescriptorName": "Gastrointestinal Microbiome"}, {"QualifierName": ["etiology", "metabolism", "prevention & control"], "DescriptorName": "Hypercholesterolemia"}, {"QualifierName": ["blood"], "DescriptorName": "Inflammation Mediators"}, {"QualifierName": ["metabolism"], "DescriptorName": "Intestinal Mucosa"}, {"QualifierName": ["drug effects", "microbiology"], "DescriptorName": "Intestines"}, {"QualifierName": ["blood"], "DescriptorName": "Lipopolysaccharides"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": ["chemistry"], "DescriptorName": "Malus"}, {"QualifierName": ["blood", "drug therapy", "etiology", "microbiology"], "DescriptorName": "Obesity"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Pectins"}, {"QualifierName": [], "DescriptorName": "Permeability"}, {"QualifierName": [], "DescriptorName": "Phytotherapy"}, {"QualifierName": [], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": [], "DescriptorName": "Rats, Sprague-Dawley"}, {"QualifierName": ["drug effects", "metabolism"], "DescriptorName": "Tight Junctions"}, {"QualifierName": [], "DescriptorName": "Time Factors"}, {"QualifierName": ["drug effects"], "DescriptorName": "Weight Gain"}]}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Hoyt C.L., Burnette J.L., Auster-Gussman L. \u201cObesity is a disease\u201d: Examining the self-regulatory impact of this public-health message. Psychol. Sci. 2014;25:997\u20131002. doi: 10.1177/0956797613516981.", "ArticleIdList": ["10.1177/0956797613516981", "24463553"]}, {"Citation": "Sassi F., Devaux M., Cecchini M., Rusticelli E. The Obesity Epidemic: Analysis of Past and Projected Future Trends in Selected OECD Countries. Organisation for Economic Cooperation and Development (OECD); Paris, France: 2009. Oecd Health Working Papers."}, {"Citation": "Jensen M.D., Ryan D.H., Donato K.A., Apovian C.M., Ard J.D., Comuzzie A.G., Hu F.B., van Hubbard S., Jakicic J.M., Kushner R.F., et al. Executive summary: Guidelines (2013) for the management of overweight and obesity in adults. Obesity. 2014;22:S5\u2013S39.", "ArticleIdList": ["0"]}, {"Citation": "Yoshimoto S., Loo T.M., Atarashi K., Kanda H., Sato S., Oyadomari S., Iwakura Y., Oshima K., Morita H., Hattori M., et al. Obesity-induced gut microbial metabolite promotes liver cancer through senescence secretome. Nature. 2013;499:97\u2013101. doi: 10.1038/nature12347.", "ArticleIdList": ["10.1038/nature12347", "23803760"]}, {"Citation": "Osborn O., Olefsky J.M. The cellular and signaling networks linking the immune system and metabolism in disease. Nat. Med. 2012;18:363\u2013374. doi: 10.1038/nm.2627.", "ArticleIdList": ["10.1038/nm.2627", "22395709"]}, {"Citation": "Miele L., Valenza V., la Torre G., Montalto M., Cammarota G., Ricci R., Mascian\u00e0 R., Forgione A., Gabrieli M.L., Perotti G., et al. Increased intestinal permeability and tight junction alterations in nonalcoholic fatty liver disease. Hepatology. 2009;49:1877\u20131887. doi: 10.1002/hep.22848.", "ArticleIdList": ["10.1002/hep.22848", "19291785"]}, {"Citation": "Backhed F., Manchester J.K., Semenkovich C.F., Gordon J.I. Mechanisms underlying the resistance to diet-induced obesity in germ-free mice. Proc. Natl. Acad. Sci. USA. 2007;104:979\u2013984. doi: 10.1073/pnas.0605374104.", "ArticleIdList": ["10.1073/pnas.0605374104", "PMC1764762", "17210919"]}, {"Citation": "Dumas M.E., Barton R.H., Toye A., Cloarec O., Blancher C., Rothwell A., Fearnside J., Tatoud R., Blanc V., Lindon J.C., et al. Metabolic profiling reveals a contribution of gut microbiota to fatty liver phenotype in insulin-resistant mice. Proc. Natl. Acad. Sci. USA. 2006;103:12511\u201312516. doi: 10.1073/pnas.0601056103.", "ArticleIdList": ["10.1073/pnas.0601056103", "PMC1567909", "16895997"]}, {"Citation": "Cani P.D., Neyrinck A.M., Fava F., Knauf C., Burcelin R.G., Tuohy K.M., Gibson G.R., Delzenne N.M. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia. 2007;50:2374\u20132383. doi: 10.1007/s00125-007-0791-0.", "ArticleIdList": ["10.1007/s00125-007-0791-0", "17823788"]}, {"Citation": "Cani P.D., Amar J., Iglesias M.A., Poggi M., Knauf C., Bastelica D., Neyrinck A.M., Fava F., Tuohy K.M., Chabo C., et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes. 2007;56:1761\u20131772. doi: 10.2337/db06-1491.", "ArticleIdList": ["10.2337/db06-1491", "17456850"]}, {"Citation": "Vijay-Kumar M., Aitken J.D., Carvalho F.A., Cullender T.C., Mwangi S., Srinivasan S., Sitaraman S.V., Knight R., Ley R.E., Gewirtz A.T. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science. 2010;328:228\u2013231. doi: 10.1126/science.1179721.", "ArticleIdList": ["10.1126/science.1179721", "PMC4714868", "20203013"]}, {"Citation": "Frazier T.H., DiBaise J.K., McClain C.J. Gut microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. JPEN J. Parenter. Enter. Nutr. 2011;35(Suppl. 5):14S\u201320S. doi: 10.1177/0148607111413772.", "ArticleIdList": ["10.1177/0148607111413772", "21807932"]}, {"Citation": "Teixeira T.F.S., Collado M.C., Ferreira C.L.L.F., Bressan J., Peluzio M.D.C.G. Potential mechanisms for the emerging link between obesity and increased intestinal permeability. Nutr. Res. 2012;32:637\u2013647. doi: 10.1016/j.nutres.2012.07.003.", "ArticleIdList": ["10.1016/j.nutres.2012.07.003", "23084636"]}, {"Citation": "Jayashree B., Bibin Y.S., Prabhu D., Shanthirani C.S., Gokulakrishnan K., Lakshmi B.S., Mohan V., Balasubramanyam M. Increased circulatory levels of lipopolysaccharide (LPS) and zonulin signify novel biomarkers of proinflammation in patients with type 2 diabetes. Mol. Cell. Biochem. 2014;388:203\u2013210. doi: 10.1007/s11010-013-1911-4.", "ArticleIdList": ["10.1007/s11010-013-1911-4", "24347174"]}, {"Citation": "Horton F., Wright J., Smith L., Hinton P.J., Robertson M.D. Increased intestinal permeability to oral chromium (51 Cr)-EDTA in human Type 2 diabetes. Diabet. Med. 2014;31:559\u2013563. doi: 10.1111/dme.12360.", "ArticleIdList": ["10.1111/dme.12360", "24236770"]}, {"Citation": "Yang P.J., Yang W.S., Nien H.C., Chen C.N., Lee P.H., Yu L.C., Lin M.T. Duodenojejunal bypass leads to altered gut microbiota and strengthened epithelial barriers in rats. Obes. Surg. 2015 doi: 10.1007/s11695-015-1968-0.", "ArticleIdList": ["10.1007/s11695-015-1968-0", "26615407"]}, {"Citation": "Turner J.R. Intestinal mucosal barrier function in health and disease. Nat. Rev. Immunol. 2009;9:799\u2013809. doi: 10.1038/nri2653.", "ArticleIdList": ["10.1038/nri2653", "19855405"]}, {"Citation": "Ma T.Y., Anderson J.M. Tight junctions and the intestinal barrier\u2014Physiology of the gastrointestinal tract (fourth edition)\u2014Chapter 61. Physiol. Gastrointest. Tract. 2006:1559\u20131594."}, {"Citation": "Ge Y., Ezzell R.M., Warren H.S. Localization of endotoxin in the rat intestinal epithelium. J. Infect. Dis. 2000;182:873\u2013881. doi: 10.1086/315784.", "ArticleIdList": ["10.1086/315784", "10950783"]}, {"Citation": "Andreasen A.S., Krabbe K.S., Krogh-Madsen R., Taudorf S., Pedersen B.K., M\u00f8Ller K. Human endotoxemia as a model of systemic inflammation. Curr. Med. Chem. 2008;15:1697\u20131705. doi: 10.2174/092986708784872393.", "ArticleIdList": ["10.2174/092986708784872393", "18673219"]}, {"Citation": "Marshall J.C., Walker P.M., Foster D.M., Harris D., Ribeiro M., Paice J., Romaschin A.D., Derzko A.N. Measurement of endotoxin activity in critically ill patients using whole blood neutrophil dependent chemiluminescence. Crit. Care. 2002;6:342\u2013348. doi: 10.1186/cc1522.", "ArticleIdList": ["10.1186/cc1522", "PMC125316", "12225611"]}, {"Citation": "Hurley J.C. Endotoxemia: Methods of detection and clinical correlates. Clin. Microbiol. Rev. 1995;8:268\u2013292.", "ArticleIdList": ["PMC172859", "7621402"]}, {"Citation": "Manuel F.R.J., Montserrat B., Crist\u00f3bal R., Joan V., Abel L.B., Wifredo R. CD14 monocyte receptor, involved in the inflammatory cascade, and insulin sensitivity. J. Clin. Endocrinol. Metab. 2003;88:1780\u20131784.", "ArticleIdList": ["12679473"]}, {"Citation": "Sweet M.J., Hume D.A. Endotoxin signal transduction in macrophages. J. Leukoc. Biol. 1996;60:8\u201326.", "ArticleIdList": ["8699127"]}, {"Citation": "Cani P.D., Rodrigo B., Claude K., Aur\u00e9lie W., Neyrinck A.M., Delzenne N.M., Burcelin R. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat diet-induced obesity and diabetes in mice. Diabetes. 2008;57:1470\u20131481. doi: 10.2337/db07-1403.", "ArticleIdList": ["10.2337/db07-1403", "18305141"]}, {"Citation": "Matter K., Aijaz S., Tsapara A., Balda M.S. Mammalian tight junctions in the regulation of epithelial differentiation and proliferation. Curr. Opin. Cell Biol. 2005;17:453\u2013458. doi: 10.1016/j.ceb.2005.08.003.", "ArticleIdList": ["10.1016/j.ceb.2005.08.003", "16098725"]}, {"Citation": "Lalles J.P. Intestinal alkaline phosphatase: Multiple biological roles in maintenance of intestinal homeostasis and modulation by diet. Nutr. Rev. 2010;68:323\u2013332.", "ArticleIdList": ["20536777"]}, {"Citation": "Hamarneh S.R., Mohamed M.M.R., Economopoulos K.P., Morrison S.A., Tanit P., Tantillo T.J., Gul S.S., Gharedaghi M.H., Tao Q., Kaliannan K., et al. A novel approach to maintain gut mucosal integrity using an oral enzyme supplement. Ann. Surg. 2014;260:706\u2013715. doi: 10.1097/SLA.0000000000000916.", "ArticleIdList": ["10.1097/SLA.0000000000000916", "PMC5034572", "25203888"]}, {"Citation": "Apovian C.M., Aronne L.J., Bessesen D.H., Nnell M.E., Hassan M.M., Uberto P., Ryan D.H., Still C.D. Pharmacological management of obesity: An endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 2015;100:342\u2013362. doi: 10.1210/jc.2014-3415.", "ArticleIdList": ["10.1210/jc.2014-3415", "25590212"]}, {"Citation": "National Institute for Health and Care Excellence . Obesity Identification, Assessment and Management of Overweight and Obesity in Children, Young People and Adults. National Institute for Health and Care Excellence (UK); London, UK: 2014.", "ArticleIdList": ["25535639"]}, {"Citation": "Melanson K.J., Angelopoulos T.J., Nguyen V.T., Martini M., Zukley L., Lowndes J., Dube T.J., Fiutem J.J., Yount B.W., Rippe J.M. Consumption of whole-grain cereals during weight loss: Effects on dietary quality, dietary fiber, magnesium, vitamin B-6, and obesity. J. Am. Diet. Assoc. 2006;106:1380\u20131388. doi: 10.1016/j.jada.2006.06.003.", "ArticleIdList": ["10.1016/j.jada.2006.06.003", "16963343"]}, {"Citation": "Woo M.N., Bok S.H., Lee M.K., Kim H.J., Jeon S.M., Do G.M., Shin S.K., Ha T.Y., Choi M.S. Anti-obesity and hypolipidemic effects of a proprietary herb and fiber combination (S & S PWH) in rats fed high-fat diets. J. Med. Food. 2008;11:169\u2013178.", "ArticleIdList": ["18361753"]}, {"Citation": "Shelly H., Corene C., Shi S., Xiuxiu S., Hoda K., Kequan Z. Dietary supplementation of grape skin extract improves glycemia and inflammation in diet-induced obese mice fed a Western high fat diet. J. Agric. Food Chem. 2011;59:3035\u20133041.", "ArticleIdList": ["21388134"]}, {"Citation": "Eslinger A.J., Eller L.K., Ra R. Yellow pea fiber improves glycemia and reduces Clostridium leptum in diet-induced obese rats. Nutr. Res. 2014;34:714\u2013722. doi: 10.1016/j.nutres.2014.07.016.", "ArticleIdList": ["10.1016/j.nutres.2014.07.016", "25156790"]}, {"Citation": "Neyrinck A.M., van Hee V.F., Piront N., de Backer F., Toussaint O., Cani P.D., Delzenne N.M. Wheat-derived arabinoxylan oligosaccharides with prebiotic effect increase satietogenic gut peptides and reduce metabolic endotoxemia in diet-induced obese mice. Nutr. Diabetes. 2012;2 doi: 10.1038/nutd.2011.24.", "ArticleIdList": ["10.1038/nutd.2011.24", "PMC3302144", "23154683"]}, {"Citation": "Licht T.R., Hansen M., Bergstrom A., Poulsen M., Krath B.N., Markowski J., Dragsted L.O., Wilcks A. Effects of apples and specific apple components on the cecal environment of conventional rats: Role of apple pectin. BMC Microbiol. 2010;10:13. doi: 10.1186/1471-2180-10-13.", "ArticleIdList": ["10.1186/1471-2180-10-13", "PMC2822772", "20089145"]}, {"Citation": "B\u00e4ckhed F., Ding H., Wang T., Hooper L.V., Koh G.Y., Nagy A., Semenkovich C.F., Gordon J.I. The gut microbiota as an environmental factor that regulates fat storage. Proc. Natl. Acad. Sci. USA. 2004;101:15718\u201315723. doi: 10.1073/pnas.0407076101.", "ArticleIdList": ["10.1073/pnas.0407076101", "PMC524219", "15505215"]}, {"Citation": "Ley R.E. Obesity and the human microbiome. Curr. Opin. Gastroenterol. 2010;26:5\u201311.", "ArticleIdList": ["19901833"]}, {"Citation": "Delzenne N.M., Neyrinck A.M., Backhed F., Cani P.D. Targeting gut microbiota in obesity: Effects of prebiotics and probiotics. Nat. Rev. Endocrinol. 2011;7:639\u2013646. doi: 10.1038/nrendo.2011.126.", "ArticleIdList": ["10.1038/nrendo.2011.126", "21826100"]}, {"Citation": "Delzenne N.M., Neyrinck A.M., Cani P.D. Modulation of the gut microbiota by nutrients with prebiotic properties: Consequences for host health in the context of obesity and metabolic syndrome. Microb. Cell Fact. 2011;10(Suppl. 1):S10.", "ArticleIdList": ["PMC3231917", "21995448"]}, {"Citation": "B\u00e4ckhed F., Crawford P.A. Coordinated regulation of the metabolome and lipidome at the host-microbial interface. BBA Mol. Cell Biol. Lipids. 2010;1801:240\u2013245.", "ArticleIdList": ["PMC2823845", "19782151"]}, {"Citation": "Caesar R., Fak F., Backhed F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J. Intern. Med. 2010;268:320\u2013328. doi: 10.1111/j.1365-2796.2010.02270.x.", "ArticleIdList": ["10.1111/j.1365-2796.2010.02270.x", "21050286"]}, {"Citation": "Diamant M., Blaak E.E., de Vos W.M. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes. Rev. 2011;12:272\u2013281.", "ArticleIdList": ["20804522"]}, {"Citation": "Geurts L., Lazarevic V., Derrien M., Everard A., van R.M., Knauf C., Valet P., Girard M., Muccioli G.G., Fran\u00e7ois P., et al. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: Impact on apelin regulation in adipose tissue. Front. Microbiol. 2011;2:149.", "ArticleIdList": ["PMC3139240", "21808634"]}, {"Citation": "Ley R.E., Backhed F., Turnbaugh P., Lozupone C.A., Knight R.D., Gordon J.I. Obesity alters gut microbial ecology. Proc. Natl. Acad. Sci. USA. 2005;102:11070\u201311075. doi: 10.1073/pnas.0504978102.", "ArticleIdList": ["10.1073/pnas.0504978102", "PMC1176910", "16033867"]}, {"Citation": "Ley R.E., Turnbaugh P.J., Klein S., Gordon J.I. Microbial ecology: Human gut microbes associated with obesity. Nature. 2006;444:1022\u20131023. doi: 10.1038/4441022a.", "ArticleIdList": ["10.1038/4441022a", "17183309"]}, {"Citation": "Million M., Maraninchi M., Henry M., Armougom F., Richet H., Carrieri P., Valero R., Raccah D., Vialettes B., Raoult D. Obesity-associated gut microbiota is enriched in Lactobacillus reuteri and depleted in Bifidobacterium animalis and Methanobrevibacter smithii. Int. J. Obes. 2012;36:817\u2013825. doi: 10.1038/ijo.2011.153.", "ArticleIdList": ["10.1038/ijo.2011.153", "PMC3374072", "21829158"]}, {"Citation": "Kohler H., McCormick B.A., Walker W.A. Bacterial-enterocyte crosstalk: Cellular mechanisms in health and disease. J. Pediatr. Gastroenterol. Nutr. 2003;36:175\u2013185. doi: 10.1097/00005176-200302000-00005.", "ArticleIdList": ["10.1097/00005176-200302000-00005", "12548051"]}, {"Citation": "Bentala H., Verweij W.R., der Vlag A.H.-V., van Loenen-Weemaes A.M., Meijer D.K., Poelstra K. Removal of phosphate from lipid A as a strategy to detoxify lipopolysaccharide. Shock. 2002;18:561\u2013566. doi: 10.1097/00024382-200212000-00013.", "ArticleIdList": ["10.1097/00024382-200212000-00013", "12462566"]}, {"Citation": "Rietschel E.T., Seydel U., Z\u00e4hringer U., Schade U.F., Brade L., Loppnow H., Feist W., Wang M.H., Ulmer A.J., Flad H.D., et al. Bacterial endotoxin: Molecular relationships between structure and activity. Infect. Dis. Clin. N. Am. 1992;5:753\u2013579.", "ArticleIdList": ["1723739"]}, {"Citation": "Chen K.T., Malo M.S., Beasley-Topliffe L.K., Poelstra K., Millan J.L., Mostafa G., Alam S.N., Ramasamy S., Warren H.S., Hohmann E.L., et al. A role for intestinal alkaline phosphatase in the maintenance of local gut immunity. Digestive Dis. Sci. 2011;56:1020\u20131027. doi: 10.1007/s10620-010-1396-x.", "ArticleIdList": ["10.1007/s10620-010-1396-x", "PMC3931260", "20844955"]}, {"Citation": "Bates J.M., Akerlund J., Mittge E., Guillemin K. Intestinal alkaline phosphatase detoxifies lipopolysaccharide and prevents inflammation in zebrafish in response to the gut microbiota. Cell Host Microbe. 2007;2:371\u2013382. doi: 10.1016/j.chom.2007.10.010.", "ArticleIdList": ["10.1016/j.chom.2007.10.010", "PMC2730374", "18078689"]}, {"Citation": "Lalles J.P. Intestinal alkaline phosphatase: Novel functions and protective effects. Nutr. Rev. 2014;72:82\u201394. doi: 10.1111/nure.12082.", "ArticleIdList": ["10.1111/nure.12082", "24506153"]}, {"Citation": "Bates J.M., Mittge E.J., Baden K.N., Cheesman S.E., Guillemin K. Distinct signals from the microbiota promote different aspects of zebrafish gut differentiation. Dev. Biol. 2006;297:374\u2013386. doi: 10.1016/j.ydbio.2006.05.006.", "ArticleIdList": ["10.1016/j.ydbio.2006.05.006", "16781702"]}, {"Citation": "Goldberg R.F., Austen W.G., Xiaobo Z., Gitonga M., Golam M., Shaluk B., McCormack M., Eberlin K.R., Nguyen J.T., Tatlidede H.S., et al. Intestinal alkaline phosphatase is a gut mucosal defense factor maintained by enteral nutrition. Proc. Natl. Acad. Sci. USA. 2008;105:3551\u20133556. doi: 10.1073/pnas.0712140105.", "ArticleIdList": ["10.1073/pnas.0712140105", "PMC2265168", "18292227"]}, {"Citation": "Visser J., Rozing J., Sapone A., Lammers K., Fasano A. Tight junctions, intestinal permeability, and autoimmunity: Celiac disease and type 1 diabetes paradigms. Ann. N. Y. Acad. Sci. 2009;1165:195\u2013205. doi: 10.1111/j.1749-6632.2009.04037.x.", "ArticleIdList": ["10.1111/j.1749-6632.2009.04037.x", "PMC2886850", "19538307"]}, {"Citation": "Cani P.D., Possemiers S., van de Wiele T., Guiot Y., Everard A., Rottier O., Geurts L., Naslain D., Neyrinck A., Lambert D.M., et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut. 2009;58:1091\u20131103. doi: 10.1136/gut.2008.165886.", "ArticleIdList": ["10.1136/gut.2008.165886", "PMC2702831", "19240062"]}, {"Citation": "Ouchi N. Adipokines in inflammation and metabolic disease. Nat. Rev. Immunol. 2011;11:85\u201397. doi: 10.1038/nri2921.", "ArticleIdList": ["10.1038/nri2921", "PMC3518031", "21252989"]}, {"Citation": "Cai D., Yuan M., Frantz D.F., Melendez P.A., Hansen L., Lee J., Shoelson S.E. Local and systemic insulin resistance due to hepatic activation of IKK- and NF-kB. Nat. Med. 2005;11:183\u2013190.", "ArticleIdList": ["PMC1440292", "15685173"]}, {"Citation": "Dandona P., Aljada A., Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol. 2004;25:4\u20137.", "ArticleIdList": ["14698276"]}, {"Citation": "Marinangeli C.P., Jones P.J. Whole and fractionated yellow pea flours reduce fasting insulin and insulin resistance in hypercholesterolaemic and overweight human subjects. Br. J. Nutr. 2011;105:110\u2013117. doi: 10.1017/S0007114510003156.", "ArticleIdList": ["10.1017/S0007114510003156", "20807459"]}, {"Citation": "Galvao Candido F., Silva Ton W.T., Alfenas R.C.G. Addition of dietary fiber sources to shakes reduces postprandial glycemia and alters food intake. Nutr. Hosp. 2014;31:299\u2013306.", "ArticleIdList": ["25561122"]}, {"Citation": "Bomhof M.R., Saha D.C., Reid D.T., Paul H.A., Reimer R.A. Combined effects of oligofructose and Bifidobacterium animalis on gut microbiota and glycemia in obese rats. Obesity. 2014;22:763\u2013771.", "ArticleIdList": ["24124012"]}, {"Citation": "Roberfroid M., Gibson G.R., Hoyles L., McCartney A.L., Rastall R., Rowland I., Wolvers D., Watzl B., Szajewska H., Stahl B., et al. Prebiotic effects: metabolic and health benefits. Br. J. Nutr. 2010;104(Suppl. 2):S1\u2013S63. doi: 10.1017/S0007114510003363.", "ArticleIdList": ["10.1017/S0007114510003363", "20920376"]}], "ReferenceList": []}], "History": [{"Year": "2015", "Month": "12", "Day": "18"}, {"Year": "2016", "Month": "2", "Day": "21"}, {"Year": "2016", "Month": "2", "Day": "22"}, {"Year": "2016", "Month": "3", "Day": "4", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "12", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["26938554", "PMC4808856", "10.3390/nu8030126", "nu8030126"]}}], "PubmedBookArticle": []}